RA CAPITAL MANAGEMENT L.P. 13D and 13G filings for Vor Biopharma Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 6:13 pm Purchase | 2025-11-12 | 13D | Vor Biopharma Inc. VOR | RA CAPITAL MANAGEMENT L.P. | 2,345,277 9.900% | 1,534,606 (+189.30%) | Filing |
| 2025-10-30 6:42 pm Sale | 2025-10-28 | 13D | Vor Biopharma Inc. VOR | RA CAPITAL MANAGEMENT L.P. | 810,671 11.500% | -375,829 (-31.68%) | Filing |
| 2025-10-27 8:06 pm Sale | 2025-10-23 | 13D | Vor Biopharma Inc. VOR | RA CAPITAL MANAGEMENT L.P. | 1,186,500 17.300% | -246,193 (-17.18%) | Filing |
| 2025-10-20 6:58 pm Sale | 2025-10-16 | 13D | Vor Biopharma Inc. VOR | RA CAPITAL MANAGEMENT L.P. | 1,432,693 20.900% | -555,964 (-27.96%) | Filing |
| 2025-09-19 4:53 pm Purchase | 2025-09-17 | 13D | Vor Biopharma Inc. VOR | RA CAPITAL MANAGEMENT L.P. | 1,988,657 29.000% | 1,988,657 (New Position) | Filing |